Last reviewed · How we verify

NCT03848975

Impact of Simulation Training for Obstetrics-gynecology Residents.

Status unknown NA Last updated 10 May 2021
What this trial tests

NA trial testing Simulation training for ECV in Simulation Training in 68 participants. Status unknown.

Timeline
28 August 2018
Primary endpoint
1 November 2022
1 November 2022

Quick facts

Lead sponsorUniversity Hospital, Geneva
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment68
Start date28 August 2018
Primary completion1 November 2022
Estimated completion1 November 2022
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Geneva

Who can join

18 and older, any sex, with Simulation Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to evaluate the benefit of simulator training for learning external cephalic version (ECV) or vacuum assisted vaginal delivery (hereafter vacuum extraction \[VE\]) for obstetrics-gynecology residents. The primary outcome of this randomized control trial is to evaluate the impact of simulation training on the success of ECV and VE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Simulation Training

Currently open trials in the same condition.

Other University Hospital, Geneva trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03848975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing